Rivastigmine is a carbamate-derived, reversible cholinesterase inhibitor, widely prescribed for mild to moderate dementia in Alzheimer’s and Parkinson’s patients. By increasing acetylcholine levels in the brain, it helps improve memory, attention, and daily functioning.
Rivastigmine
CAS No.: 123441‑03‑2
Therapeutic Category: Acetylcholinesterase Inhibitor (used in Alzheimer’s & Parkinson’s dementia)
Molecular Formula: C₁₄H₂₂N₂O₂
Appearance: White to off-white crystalline powder
Pharmacopeial Standards:
✔ United States Pharmacopoeia (USP)
✔ European Pharmacopoeia (Ph. Eur)
✔ In-house analytical specifications
DMF (Drug Master File): Available
Manufactured in India under WHO‑GMP / USFDA‑compliant facilities
Reviews
There are no reviews yet.